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The gut-associated lymphoid tissue (GALT) consists of isolated or aggregated lymphoid follicles forming Peyer’s patches (PPs).
By their ability to transport luminal antigens and bacteria, PPs can be considered as the immune sensors of the intestine. PPs
functions like induction of immune tolerance or defense against pathogens result from the complex interplay between immune
cells located in the lymphoid follicles and the follicle-associated epithelium. This crosstalk seems to be regulated by pathogen
recognition receptors, especially Nod2. Although TLR exerts a limited role in PP homeotasis, Nod2 regulates the number, size, and
T-cellcomposition ofPPs,in responsetothe gut ﬂora.Inturn,CD4+ T-cellspresent inthe PPare able tomodulate the paracellular
and transcellular permeabilities. Two human disorders, Crohn’s disease and graft-versus-host disease are thought to be driven by
an abnormal response toward the commensal ﬂora. They have been associated with NOD2 mutations and PP dysfunction.
1.Introduction
In the gut, discrimination between pathogens and commen-
sal bacteria is achieved by the interaction of the intestinal
epithelium with lymphoid cells. The gut-associated lym-
phoid tissue (GALT) consists of both isolated and aggregated
lymphoid follicles [1] and is one of the largest lymphoid
organs, containing up to 70% of the body’s immunocytes.
Aggregated lymphoid follicles were initially described by
Marco Aurelio Severino in 1645 in Italy. They were named
Peyer’s Patches (PPs) after their detailed description by the
Swiss pathologist Johann Conrad Peyer in 1677. PPs are
composed by aggregated lymphoid follicles surrounded by
a particular epithelium, the follicle-associated epithelium
(FAE) that forms the interface between the GALT and the
luminal microenvironment. The FAE contains specialized
cells named M (for microfold) cells. These M-cells are
able to transport luminal antigens and bacteria toward the
underlying immune cells that activate or inhibit the immune
response leading to either tolerance or systemic immune
cell response. The aims of this paper are to describe the
diﬀerent actors and functions of the PP, their implication
in the induction of immune tolerance and defense against
pathogens and ﬁnally their role at the interface between
innate and adaptive immunity.
2.Development, Architecture,and
Functions of Peyer’s Patches
The postnatal development of PPs has been initially inves-
tigated by Cornes who reported in 1965 that the number
of PPs peaks at ages 15–25 and then declines during the
life [2]. Van Kruiningen et al. conﬁrmed these ﬁndings [3]
and noted that, in addition, the area occupied by PPs in the
ileum is maximum in the third decade [4]. In the human
small intestine, PPs are oval and irregularly distributed along
the antimesenteric side of the gut [2]. At the opposite,
in the distal ileum, they are numerous and they form a
lymphoid ring [4]( Figure 1). Indeed, at least 46% of PPs are
concentrated in the distal 25cm of ileum in Human [4]. It
is to note that there are large variations in size, shape, and
distribution of PPs from one individual to another one. The
consequences of these variations on the physiological and/or
pathological parameters related to PP functions remains to
be elucidated [2, 4].
2.1. Development of Peyer’s Patches
In Human. The fetal human small intestine contains in
average 60PPs before week 30 of gestation and their number
steadily increase reaching a maximum of 240 at puberty [2].2 International Journal of Inﬂammation
Baginskys and others identiﬁed distinct clusters of T and B
cells in the small intestine at 14–16 weeks of gestation [2, 5–
8]. At week 19, these aggregates mature into recognizable
PPs containing follicular dendritic cells (FDCs) and become
macroscopically discernable at week 24, even though no
germinal centers are present. The latter rapidly develop after
birth, when the intestines are exposed to commensal bacteria
and antigens [2]. Although macroscopic descriptions of
human PP are available, no information concerning the
embryonic steps of PP development is actually reported
whereas the diﬀerent steps of PP genesis have extensively
been studied in mice.
In Mouse. Three successive steps have been evidenced in
PP formation in mouse. The ﬁrst one, at embryonic day
15.5 (E15.5), marks the beginning of PP development. At
that time, VCAM-1 is expressed by distinct clusters of
stromal cells located on the antimesenteric side of the small
intestine [9]. These VCAM-1 positive cells also express the
ligand of the tyrosine kinase receptor RET [10]. During
the second step (between E15.5 and E17.5), VCAM-1
positive cells recruit RET+CD11c+cKit+lymphotoxin+ cells
and IL7R+lymphotoxin+CD4+CD3− LTic (Lymphoid Tissue
inducer cells) [9–11]. The VCAM-1-positive stromal cells
express the lymphotoxin β (LTβ) receptor, and upon ligation
of this receptor produce IL7 and homeostatic chemokines
such as CXCL13 [12]. This reciprocally leads to increased
expression of surface lymphotoxin on LTic, forming a self-
sustaining PP primordium [13, 14]. Gene inactivation of
CXCL13 and LTβ-receptor interrupts the interaction of LTic
with organizer cells and thus abolishes PPs development.
Similarly, injection of LTβRf u s e st oat r u n c a t e dh u m a n
immunoglobulin competitively interferes with LTβR signal-
ing by organizer cells and interferes with PP development.
Since E17.5, during the third phase of PP genesis, circulating
lymphocytes are attracted. They enter into the developing
organs and ﬁll up the T and B cell niches [11]. While the
embryonic genesis of PPs is largely known, their postnatal
development is actually poorly understood (see Section 4.1).
2.2. Architecture of Peyer’s Patches. Morphologically, PPs are
separated into three main domains: the follicular area, the
interfollicular area and the follicle-associated epithelium [1].
The follicular and interfollicular areas consist of the PP
lymphoid follicles with a germinal center (GC) containing
proliferatingB-lymphocytes,folliculardendriticcells(FDCs)
and macrophages. The follicle is surrounded by the corona,
or subepithelial dome (SED) containing mixed-cells includ-
ing B-cells, T-cells, macrophages and dendritic cells (DCs).
PPs are connected to the body by lymphatic vessels and
endothelial venules. Na¨ ıve lymphocytes immigrate into the
PP via specialized high endothelial venules. Na¨ ıve or active
lymphocytes leave the PP via eﬀerent lymphatic vessels at
the serosal side of the PPs which connect the PPs to the
mesenteric lymph nodes (MLN). The arched appearance
of PPs is due to the GC forming the core of each follicle
(Figure 2).
The follicle-associated epithelium (FAE) diﬀers from
the epithelium of the villus mucosa: the production of
Figure 1: Peyer’s patches in the distal ileum. PPs seen in a 20-years-
old man during ileocolonoscopy. Note that PPs form a lymphoid
ring in the distal ileum.
mucus is weak; the membrane-bound digestive enzymes are
lightly expressed and the enterocyte brush border glycocalyx
has diﬀerent glycosylation patterns [15–17]. FAE is also
characterized by a large number of inﬁltrated B-cells, T-
cells, macrophages and DCs. Finally, the FAE lacks the
subepithelial myoﬁbroblast sheath and, the basal lamina is
more porous compared with the regular epithelium [18, 19].
FAE are constantly renewed from precursor cells located
in adjacent crypt zones [20]. The main feature of FAE is the
presence of M-cells which are specialized enterocytes. M-
cells diﬀerentiate from enterocytes under the inﬂuence of
membrane-bound lymphotoxin (LTα1β2) present on local
lymphoidcells,mainlyB-cells[21].Thecellularcomposition
of the FAE (i.e., the proportion of enterocytes and M-
cells) may be modulated by bacteria present in the gut
lumen. For example, the number of M-cells in FAE is
increased after transfer of mice from pathogen-free to
normal housing conditions [22]. Pathogenic bacteria like
Streptococcus pneumoniae or Salmonella typhimurium may
increase the number of M-cells within the FAE [23, 24].
Thus the FAE exhibit an astonishing phenotypical plasticity
and can rapidly change its functions depending on host or
bacterial stimuli.
M-cells are specialized in the transcytosis of intact
luminal material like soluble proteins, antigens, bacteria
andviruses[25].Endocytosis,phagocytosis,pinocytosis,and
macropinocytosis are all mechanisms used for the ingestion
of the extracellular material. M-cells highly express diverse
glyco-signatures which may be exploited as receptors by
somemicrobes[25].TheyalsoexpressIgAreceptorsallowing
the capture and uptake of IgA trapped bacteria [26]. As
a result, luminal IgA not only prevents penetration of
bacteria/pathogen into the mucosa but also redirects them
to the M cells and PPs [27].
The paracellular permeability is diﬀerentially regulated
into the FAE [28, 29]. Compared with intestinal mucosa,
the FAE exhibits an increased expression of claudin-3 and
occludin, which are both described to downregulate the
opening of tight junctions. [28]. On the contrary, claudin-2International Journal of Inﬂammation 3
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Figure 2: Histological features of a Peyer’s patch. Three follicles are individualized. Arrows show the germinal center (GC); subepithelial
dome (SED) and follicle associated epithelium (FAE) for one of these follicles.
(which is known to have an opposite eﬀect), is less expressed
in FAE than in the villus epithelium [28] .T h es i t eo f
expression may vary within the FAE: claudin-3 and occludin
are expressed throughout the dome whereas claudin-4 is
preferentially seen in the apex region of the dome [28]a n d
Claudin-2 in the boarding villus epithelium [28]. Moreover,
Clark and Hirst found that the adherens junctions of murine
M-cells could be recognized by enhanced expression of
β-catenin, α-actinin, and polymerized actin [29].
2.3. Cellular Composition of Peyer’s Patches
In Human. Because it is diﬃcult to identify and collect
PPs during routine endoscopies, studies of human mucosal
lymphoid follicles are rare and limited to young patients. In
human, among the mononuclear cells (MC), CD4+/CD25+
(10%) cells and CD8+/CD25+ (5%) cells are more abundant
in PPs than in the peripheral blood [30]. Nagata et al.
observed that after incubation with β-lactoglobulin, CD4+
and CD8+ T-cells from PPs were orientated toward a Th1
proﬁle (characterized by the production of IFNγ)b u tn o t
toward a Th2 proﬁle (characterized by IL-4 secretion) [30].
Junker et al. investigated the cellular subsets within the
isolatedlymphoidformations(ILFs)[31].T -c ellsw er efound
more frequently CD4+ and CD62L+ than CD8+ and CD103+
cells [31]. In addition, antiCD3/CD28 stimulation induced a
proliferation of T-cells associated with the secretion of high
levels of IFNγ,T N F α and interleukin (IL)-2, but low levels
of IL-4, IL-6 and IL-10 [31], conﬁrming that PPs present
a Th1 rather than a Th2 proﬁle. Whereas very few papers
report human PP’s cellular composition, mouse PPs have
extensively been studied.
In Mouse. PP exhibit about 60% of B-cells (B220+), 25% of
T-cells (CD3+), 10% of dendritic cells (CD11c+) and less
than 5% of macrophages (F4/80+) or polymorphonuclear
neutrophil (Ly-6G+). Among T-cells, 45% are CD4+, 35%
are CD8+ and 20% are CD4−/CD8− T-cell. Among CD4+
T cells, 85% are memory T-cells (CD25−CD45RBlo), 10%
are Naive (CD25−CD45RBhi) and 5% are regulatory T-
cells (CD25+CD45RBlo)[ 32]. Distinct subsets of DCs,
based on their cell-surface marker expression, together
with their location, have been identiﬁed in PP [33,
34]. All the subsets express CD11c and major histocom-
patibility complex class II antigens but diﬀer for their
expression of CD8α (lymphoid) and CD11b (myeloid)
molecules.LymphoidCD11c+CD8α+CD11b− DCsarelocal-
ized within the T-cell–rich interfollicular regions [33].
Myeloid CD11c+CD8α−CD11b+ DCs are present under
the FAE in the SED [33]. Finally, the “double negative”
CD8α−CD11b− DCsarefoundintheSED,theinterfollicular
region, and within the FAE [33].
In comparison with DCs from spleen (SP), DCs derived
from PPs exhibit strong functional diﬀerences [35]. PP
DCs are more potent in stimulating allogeneic T-cells
proliferation compared with DCs from SP, and DCs derived
from PPs, but not from SP, are able to prime the production
of IL-4 and IL-10 (Th2 anti-inﬂammatory cytokines) [35].
In addition, PP DCs prime T-cells for the production of
much lower levels of IFNγ (Th1 inﬂammatory cytokine)
compared with SP DCs. Finally, stimulation of PP DCs with
CD40 molecule resulted in secretion of high levels of IL-
10, whereas the same stimulus induced no IL-10 secretion
from SP DCs. All DC subpopulations derived from PP
secrete a distinct pattern of cytokines upon exposure to T-
cells and microbial stimuli. CD8α+CD11b− (lymphoid) and
double negative DCs share similar functional characteristics
as they both orientate the T-cells toward a Th1 proﬁle,
notably via IL-12 secretion upon bacterial stimulation [34].
In contrast, only CD8α−CD11b+ myeloid DCs produce
high levels of IL-10 upon stimulation with CD40 ligand,
or Staphylococcus aureus. In addition, myeloid DCs are
particularly capable of priming naive T cells to secrete high
levels of IL-4 and IL-10 (Th2 anti-inﬂammatory cytokines),
when compared with those from extramucosal sites, while
lymphoid and double negative DCs from all tissues
prime for IFNγ (Th1 inﬂammatory cytokine) production
[34].4 International Journal of Inﬂammation
Very recently, a new subset of myeloid dendritic cells
(CD11c+CD11b+) has been identiﬁed in the subepithelial
dome of mouse and human PP. These DCs strongly express
lysozyme and are able to internalize bacteria and dead cells.
Moreover these DCs possess the machinery required to eﬃ-
ciently present antigens to the immune cells—class II major
histocompatibility complex and costimulatory molecules—
thus actively participating in the ﬁrst immune defense line
within PPs [36].
2.4. Involvement of Peyer’s Patches in the Induction of Oral
Immune Tolerance. The function of PPs was unknown until
1922, when Kenzaburo Kumagai reported an uptake of
Mycobacterium tuberculosis inside the epithelial dome of
PP. However, as he also observed an uptake of heat-killed
bacteria and sheep red blood cells by PPs, he concluded that
this uptake was a nonspeciﬁc process. Nevertheless, Owen
and Jones showed in 1974 that M-cells were able to take up
antigens highlighting the role of PPs in the immune system
[15].
Immunological tolerance against non-pathogenic bac-
teria and antigens is a phenomenon observed along the
gastrointestinal mucosa [37] which avoids reactions against
proteins and commensal bacteria. Oral tolerance is an active
process, leading to the generation of antigen-speciﬁc T
lymphocytes that suppress further immune stimulation. It is
deﬁned by the antigen-speciﬁc suppression of both cellular
and humoral immune responses to orally administered
antigens. In addition to the generation of suppressive T
cells, anergy and T cell deletion have been described as
mechanisms underlying oral tolerance [38]. Consequently,
mucosal tolerance protects the mucosa from detrimental
inﬂammatory immune responses. The activation involved in
the tolerance induction process to proteins is also important
for the maturation of the immune system. As an example,
mice feed with a protein-free diet exhibit an underdeveloped
GALT with low amounts of immunoglobulin A together
with a systemic Th2 proﬁle [39]. A defect in the generation
of suppressive T-cells against food or commensal bacterial
antigenscouldleadtofoodhypersensitivityandceliacdisease
[40, 41]. Consequently, mucosal tolerance protects the
mucosa from detrimental inﬂammatory immune responses.
Oral tolerance to a broad variety of antigens involves
the suppression of diﬀerent types of immune responses,
including delayed hypersensitivity and antibody production.
PPs have been extensively studied for their contribution to
m u c o s a lt o l e r a n c e ,b u tt h e i rp r e c i s er o l ei ss t i l lu n c l e a r .A f t e r
oral administration of antigens, PPs are the ﬁrst places of
T-cell-speciﬁc priming and proliferation in the gut [42].
Mice lacking PPs fail to generate an oral tolerance against
ovalbumin but develop an oral tolerance toward small
chemical haptens like TNBS suggesting that organized PPs
areinvolvedinproteinunresponsivenesswhileepithelialcells
modulates the response to smaller molecules [43]. However
other observations suggest that this point of view may be
too simple: surgical removal of PPs does not interfere with
the ability of rats to develop an oral tolerance [44]; an oral
tolerance toward proteins has been reported in mice lacking
PPs in speciﬁc conditions [45, 46]; and the administration
of antigens in isolated intestinal loops with or without PPs
induced a tolerance in both conditions [47]. Noteworthy,
gradual decline in PP immunological functions has been
implicated in the lack of oral tolerance in aging mice [48].
Thus, if PPs are clearly very eﬃcient in the uptake and
handling of antigens, their exact role in the induction of oral
tolerance remains to be clariﬁed.
2.5. Role of Peyer’s Patches in the Defense against Pathogens.
As previously described, the FAE and M-cell phenotypes
are optimized for antigen and microorganism uptake and
handling. The mechanisms by which M-cells take up
microorganisms and macromolecules vary according to the
nature of the biological material. Large particles and bacteria
induce phagocytosis, which is often associated with ruﬄing
of the apical plasma membrane of the M cell and rear-
rangement of the actin cytoskeleton, which permits active
formation of pseudopodia-like structures [49, 50]. Viruses
and other adherent particles are taken up by endocytosis
via clathrin-coated vesicles, whereas non-adherent material
is internalized by ﬂuid phase endocytosis [27, 51, 52]. In all
these cases, internalization is followed quickly by transport
of endocytotic vesicles to the endosomal compartment and
thenbyexocytosistothebasolateralmembrane.PPsampling
of the lumen is crucial for protective mucosal immune
responses.Asacounterpart,PPsprovidearouteofentryinto
the organism for various pathogenic agents such as bacteria,
viruses, protozoa or prion.
Bacteria. Among the pathogenic bacteria with a digestive
tropism such as Escherichia coli, Yersinia, Mycobacterium
avium paratuberculosis, Listeria monocytogenes, Salmonella
typhimurium and, Shigella ﬂexneri, all of them have been
reported to invade the host by adhering with FAE M-cells.
Most of the strains of E. coli do not adhere to M-cells but
the Enterohaemorrhagic E. coli (EHEC) and enteropathogenic
E. coli (EPEC) show speciﬁc adherence to FAE when
cocultured with human intestinal biopsies [53, 54]. Infection
withtheEHECstrainO157:H7causesdiarrhea,hemorrhagic
colitis and hemolytic uremic syndrome [55]. This strain
selectively adheres to FAE by its intimin-γ protein and
binds the β1-integrins expressed on the M-cell apical surface
[56, 57]. Other enteropathogenic E. Coli strains (like EPEC
RDEC-1) adhere to the M-cells but with a mechanism
independent of intimin [58, 59]. Finally, some EPEC strains
like O127:H7 exhibit a similar rate of translocation across
M-cells and enterocytes in vitro [60]. In addition, it was
observed that translocation rates were signiﬁcantly increased
in the absence of a functioning Type III secretion system
[60].
Yersinia enterocolitica and Y. pseudotuberculosis are
human foodborne pathogens that cause clinical ileitis or
ileocolitis. Yersinia species adhere to both enterocytes and
M-cells but with a preference for M-cells [61–63]. Y.
enterocolitica and Y. pseudotuberculosis targets the M-cells via
the molecular interaction between the β1 integrins present
on the host cell and invasin, an outer-membrane Yersinia
protein [61, 62, 64]. As a result, Yersina causes major
damages to PPs and bacterial mutants lacking the invasinInternational Journal of Inﬂammation 5
protein display reduced colonization and translocation of
PPs in vivo [57, 62].
Paratuberculosis or Johne’s disease is a chronic enteritis
of the cattle and other small ruminant caused by Mycobac-
terium avium paratuberculosis (MAP).I nh u m a n ,M A P
ingestion causes acute and chronic enteritis. MAP are able to
invade the intestinal mucosa by interacting with enterocytes
[65]andM-cells[66,67].In vitro studieshaveshownthatthe
attachment and the internalization of MAP by epithelial cells
depend on the interaction between Fibronectin attachment
proteins and ﬁbronectin [68–70]. In fact β1 integrins are the
host cell receptors for ﬁbronectin-opsonized mycobacteria
[68, 71]. Because M-cells are the unique intestinal cells
expressing β1 integrins at a high density on their luminal
surface, they represent the main entrance site for MAP
[64].
Listeria monocytogenes is the causative agent of human
listeriosis, a potentially fatal foodborne infection. Clinical
manifestations range from febrile gastroenteritis to more
severe invasive forms, including sepsis, meningitis and
rhombencephalitis. L. monocytogenes invades nonphagocytic
cells such as enterocytes and this process is critical for
bacterial translocation through the intestinal epithelium
[72, 73]. While it is clear that the pathogen interacts with
the enterocytes via internalins, several observations suggest
that L. monocytogenes has also the potential to invade their
host via M-cells. First, a rapid localization of L. monocyto-
genes into mouse PPs has been reported [74, 75]. Second,
L. monocytognenes migrates through diﬀerentiated M-cells
more eﬃciently than in non diﬀerentiated cells in vitro
[75]. Finally, in vivo analysis of orogastric L. monocytogenes
infections showed a preferential replication within the PPs
with an extremely rapid translocation to internal organs
[76,77]. Moreover, it has been shown that L.monocytognenes
migrates through diﬀerentiated M-cells more eﬃciently than
in non diﬀerentiated M-cells [75].
In contrast with Mycobacterium [49]o rYersinia [61,
78], which have been shown to speciﬁcally attach to and
pass through M-cells without modiﬁcations or died M-cells,
Shigella ﬂexneri [79]a n dSalmonella typhimurium [80, 81]
areknowntoalterM-cellhomeostasisandfunctions.Shigella
ﬂexneri requires both an adhesive and invasive phenotype
to eﬃciently colonize FAE. Following Shigella infection, M
cells begin to increase in size, which eventually disrupts
the integrity of the epithelium [79]. The eﬀect of invasive
Salmonella typhimurium on M-cells is dramatic [80, 81]. At
the earliest stages of Salmonella invasion, large membrane
ruﬄes appear on the apical surfaceof the M-cells, and within
a short period of time (30 to 60 min), the cells becomes
necrotic and begins to die. Finally, although PPs have been
recently involved in the Helicobacter pylori induced gastritis,
it has been observed that the translocation of H. pylori across
PPs is performed by DC [82]. Thus, no gastritis is induced in
H.pylori-infectedmicelackingPPsandithasbeenevidenced
that the coccoid form of H. pylori is phagocytosed by DC in
PPs [82].
Together, these ﬁndings indicate that enteric pathogens
have evolved distinct mechanisms to interact, invade and
destroy PPs. Although the majority of enteric bacteria alter
PP homeostasis by interacting and invading M cells from
FAE, DCs inside FAE seem to play an alternative pathway.
Viruses. Several viruses like Reovirus type-1, Poliovirus and
HIV type 1 are transported by M-cells [83–85].
Reovirus isanorallytransmittedmurinepathogen,which
aﬀects the nervous system, causing encephalitis. Reovirus
type-1 selectively adheres to M-cells by interacting with α-2-
3-linked sialic acid glycoconjugates expressed by M-cell [86].
The infection causes a depletion of the M-cells from the FAE
[87].
Poliovirus is the causative agent of poliomyelitis. It infects
humans via the oral route. PPs are the primary sites of virus
replication in the gut [83]. In human infected tissues, virions
were speciﬁcally found on the surface and in intracellular
vesicles of M-cells [83].
Transmission of HIV type 1 (HIV-1) infection via
anorectal, cervicovaginal, foreskin and urethral epithelia
accounts for 80% of AIDS cases [84]. HIV-1 is able to cross
the mucosal barrier of the intestinal or genital tracts to
infect CD4+ T-cells. HIV-1 can adhere to M-cells—via the
chemokine receptor CXCR4 expressed apically on M-cells
[88] but not to enterocytes [84].
Prion. Transmissible spongiform encephalopathies (TSE)
are characterized by the accumulation of a protease-resistant
abnormal isoform of the prion protein (PrPSc) ,w h i c hi sc o n -
verted from the cellular isoform of the prion protein (PrPc).
After oral transmission, PrPSc can invade the host through
PPs [89–91]. In mouse models, reduced PP numbers have
been associated with a higher resistance to orally acquired
prion infection [91]. Moreover, it has been suggested that
the prion protein migration from the gut to the lymphoid
system also involve M-cells [92]. Finally, the replication and
the accumulation of prion during TSE seem to be located in
the FDCs of PP. Altogether, these studies argue for a major
role of PPs in TSE pathogenesis [93–95].
3.Peyer’s Patches:A Key Organ of
the Relationship betweenInnateand
AdaptativeImmunityinthe Gut
3.1. The Nod2 Sensor in Peyer’s Patches. Pathogen associated
molecular patterns (PAMPs) present on commensal and
pathogenic bacteria are recognized by pathogen recognition
receptors (PPRs) present in the host cells. Among the
PAMPs, the Toll like receptors (TLRs) and the Nucleotide
oligomerisation domain (NODs) are largely expressed in
follicle associated cells such as epithelial or dendritic cells.
TLRs are mainly extracellular sensors whereas the Nods are
cytoplasmic. TLRs and Nods are triggered by a diﬀerent
set of PAMPs. Particularly, Nod2 is able to recognize the
muramyl dipeptide (MDP) a component of the peptido-
glycan bacterial wall present in most Gram+ and Gram−
bacteria. Common NOD2 variants have been associated with
Crohn’s Disease (CD) [96, 97] and graft-versus-host disease
(GVHD) [98, 99]. The main CD and GVHD associated
variants—R702W, G908R and 1007fs—are located within or6 International Journal of Inﬂammation
near the Leucin rich repeat domain (LRR) that is supposed
to interact with the MDP. [98–100].
While lymphotoxin and IL-7 signalling are essential for
the organogenesis of PP during the embryonic stage, studies
on germ-free animals argue for a critical role of the gut ﬂora
during postnatal development [1]. Germ-free animals have
an underdeveloped GALT and are resistant to experimental
colitis and to severe GVHD [101], suggesting that bacterial
sensors could be implicated in PP development and the
Human diseases. Whereas, it has been evidenced a reduction
of PP size in TLR deﬁcient mice [102], invalidated mice for
Nod2 gene(Nod2−/−)ar ec haract eriz edb yah ypertr o ph yand
ahyperplasiaoftheGALT[32,103].AfterbirthNOD2mut/mut
mice carrying a frameshift mutation homologous to the
Human 1007fs variant exhibit a phenotype comparable to
that of Nod2−/− mice [103].
In fact, Nod2 seems to play a pivotal role in the GALT
homeostasis in response to commensal bacteria [104]. The
expression of Nod2 depends on the presence of commensal
bacteria: while its expression in the terminal ileum of mice
rederived into germ-free conditions decreased signiﬁcantly,
it is induced by commensal bacteria into germ-free mice
[104]. In addition, chronic antibiotic therapy abrogates the
overdevelopment of the GALT in Nod2−/− mice [103]. Gut
microﬂora exerts a strong stimulation on the Nod2−/− PPs
mice,inducingahighproportionofCD4+ T-cells,highlevels
of inﬂammatory cytokines and high permeability rates for
antigens and bacteria [103]. In turn, the terminal ileum
of Nod2−/− mice exhibits an elevated load of commensal
bacteria and its ability to prevent intestinal pathogenic
bacteria colonization is diminished [104]. As a result, Nod2
appears to play a key role in the regulation of the interaction
between PP and the gut ﬂora.
3.2. Nod2: A Link between Innate Immunity and Adaptative
Immunity. Nod2 appears not only to inﬂuence the develop-
ment of the GALT but it is also able to modulate the immune
response toward bacteria, by limiting the development of
a Th1 immune response. In wild type mice DCs, MDP
acts synergistically with lipopolysaccharid (LPS)—the TLR4
ligand—to promote the proliferation of na¨ ıve CD4+ T-cells
with a Th2-like cytokine proﬁle. By contrast, DCs carrying
Nod2 mutations are unable to react to MDP, but respond
to LPS and promote the development of Th1-orientated
cells [105]. As a result, Nod2 seems to limit the ability of
DCs to induce a polarised Th1 response of CD4+ T-cells
[105].Similardatahavebeenevidencedinmice,whereNod2
stimulation by MDP triggers a potent age-speciﬁc immune
response with a Th2-type polarization proﬁle, characterized
by the induction of IL-4 and IL-5 by T cells and IgG1
antibody responses [106]. Nod2 was also found to be critical
for the induction of both Th1- and Th2-type responses
following costimulation with TLR agonists [106]. Because
this synergistic response was recapitulated by DC in vitro,
it can be supposed that DCs likely play a central role in the
integration of Nod2- and TLR-dependent signals for driving
the adaptive immune response [106]. Together, these data
identify Nod2 as a critical mediator of microbial-induced
potentiation and polarization of age-dependent immunity.
In the absence of Nod2, PPs present a higher rate of
CD4+ T-cells and M-cells in the FAE and increased levels
of Th1 (IFNγ,T N F α and IL-12) and Th2 (IL-4) cytokines.
These immune alterations are associated with an increased
of paracellular permeability and yeast/bacterial translocation
[32]. Indeed, PPs from Nod2 −/− mice exhibit an elevated
translocation of Escherichia coli, Staphylococcus aureus and,
Saccharomyces cerevisiae [32]. This increase of microbes
passage is mediated by an upregulation of myosin light
chain kinase expression and activity [103]. CD4+ T-cell
depletion and IFNγ-blocking antibodies in Nod2 deﬁcient
mice abrogated this phenotype [103]. Altogether, these data
suggest that Nod2 modulates the adaptive immune response
of PPs and may promote the immune tolerance. As a result,
Nod2 also regulates the intestinal barrier function, limiting
the paracellular and transcellular permeabilities together
with bacterial translocation.
Altogether, these data support the contribution of Nod2
in the immunogenic tolerance toward gut microﬂora and a
key role of Nod2 inCD4-Tcellsfunction.Studiesfocusingon
GVHD also argue for the capacity of Nod2 to regulate the T-
cellresponse.GVHDisacommoncomplicationofallogeneic
stem cell transplantation, which occurs when donor-derived
T-cells are stimulated by host antigen-presenting cells. Acute
GVHD is characterized by damages mainly in the skin, the
liver, the gastrointestinal tract and other mucosae. Using
an experimental model of Nod2 chimeric mice, Penack and
coworkers have shown an exacerbated GVHD in case of
allogenic transplantation of Nod2+/+ mice with Nod2−/−
bone marrow cells [107]. As expected, this phenotype was
associated with an increased activation and proliferation
of alloreactive donor T-cells and Nod2 deﬁcient DCs were
involved in the phenotype [107]. At the opposite, allogenic
transplantation of Nod2−/− mice with Nod2+/+ bone mar-
row cells had no signiﬁcant impact on the development
of GVHD [107]. However, this important role of Nod2
in the T cell function does not seem to be conﬁrmed
in human. In human, GVHD proceeded by an allogenic
stem cell graft and immunosuppressive prophylaxis, the
analysis of biopsies from intestinal GVHD showed a decrease
of CD4+-T cells inﬁltrate when recipient carried NOD2
GVHD associated variants whereas the donor NOD2 status
had no signiﬁcant impact on the CD4+ cell inﬁltrates
[108].
Nod2 also plays a role in the immune response to
pathogens. For example, Nod2 deﬁcient mice are more
susceptible to Toxoplasma gondii infection [109]. This obser-
vation was associated with a defect of IFNγ production
by Th1 lymphocytes. Interestingly, this phenotype was not
due to a lack of CD4+ T-cell activation by DCs. In a
model of Mycobacterium tuberculosis infection, Divangahi
et al., showed that Nod2 deﬁcient mice exhibited a decreased
production of Th1 cytokines—IFNγ and TNFα—as well
as a reduced recruitment of CD4+ and CD8+ Tc e l l s
[110].
If Nod2 modulates the adaptive immune response, its
mechanisms of action are probably multiple. In human
monocytes-derived DCs Nod2 is able to induce the
autophagy after activation by the MDP. By consequence,International Journal of Inﬂammation 7
it promotes bacterial handling and activates the major
histocompatibility complex class II antigen-speciﬁc CD4+
T cell responses [111]. Nod2 activation also enhances the
TLR-dependentinductionofIL-1andIL-23,thuspromoting
Th17 orientated T-cells which have been implicated in
antimicrobial response [112]. Finally, the study of Shaw
et al. argues for a proper role of Nod2 in T-cell function
independently of DCs and MDP induction. In their model
of T.gondii infection, DCs from Nod2 deﬁcient mice were
able to activate a normal response of wild type T-CD4+
to T.gondii suggesting an intrinsic role of Nod2 in the
generation of an eﬀective Th1 response [109]. Moreover
Rick was not necessary to protect against T.gondii suggesting
the implication of a pathway independent of the Nod2-
MDP-activation in CD4+ T-cells [109]. Similarly, it has been
recently evidenced that NOD2 exerts an important role in
the human regulatory T-cells (Treg cells): NOD2 stimulation
results in the upregulation of antiapoptotic genes in human
Treg cells [113]. In addition, Crohn’s disease NOD2 variants
are associated with a deﬁciency of FOXP3+ Treg cells in the
colonic lamina propria [113].
Although the diﬀerent mechanisms by which Nod2
promote T-cell response are not fully understood it appears
now clearly that Nod2 has a role not only in innate immunity
but also in adaptive immunity.
4.Peyer’s Patches andHumanDiseases
4.1. Crohn’s Disease. Crohn’s disease (CD) is an inﬂam-
matory disorder characterized by a chronic or relapsing
inﬂammation of the digestive tract. A key role of PPs in CD
hasbeensupportedbyaspatiotemporalrelationshipbetween
the CD lesions and PPs and by the pathogenesis on CD
whichissupposedtoresultofaninappropriateinnateand/or
adaptative immune response to the bacterial ﬂora.
CD can aﬀect all the digestive tract areas with a
preference to the terminal part of the ileum where PPs
are more numerous [4]. The number and size of PPs
increase from birth to 15–25 years old and then decline
with age. This curve is roughly parallel with the age-
incidence curve of CD, [114] this is especially true for the
ileal presentation of the disease considering that ileal CD
is rare in young children and seniors [115, 116]. These
observations argue for a temporal relationship between PP
development and CD as proposed by Van Kruiningen et al.
[2, 4, 115]. Finally, the very early CD lesion, a tiny ulcer
called aphtoid lesion has been found by several authors
to be centered by lymphoid follicle formations [117–119].
In carefully performed correlative studies with magnifying
endoscopy and scanning electron microscopy, Fujimura
and coworkers demonstrated that the aphtoid lesions of
CD are preceded by ultrastructural erosions (150–200
microns in size) in the FAE of hyperemic lymphoid follicles
[4, 120].
It is largely admitted that CD is associated with an
abnormal T-cell-mediated immune response toward the gut
ﬂora. Inﬂammatory lesions of CD (i.e., aphtoid lesion and
ulcers) are more pronounced in the terminal ileum and
colon which contain the highest densities of bacteria. The
partial eﬃcacy of antibiotics and fecal diversion in CD
patients also highlight the fundamental role of bacteria in
CD pathogenesis. Now, several genes implicated in bacterial
recognition and/or innate immunity including NOD2 but
also the autophagic genes ATG16L1 and IRGM have been
implicated in genetic CD susceptibility. Actually, studies on
CD microbiota have found evidence for decline in bacterial
diversity in CD patients, compared to controls [121, 122].
BecausePPsarespecializedinsamplingandpresentinglumi-
nal antigens and bacteria to the underlying immune cells, a
few authors have studied the role of PPs in CD pathogenesis.
Keita et al. have shown an increased translocation of non
pathogenic E. Coli associated with an increased percentage of
E. Coli colocalizing with DCs in PPs of ileal CD compared
to controls [123]. More recently, these DCs have been
characterized by FACS analysis and immunoﬂuorescence
microscopy, leading to the identiﬁcation of a subset of
mature CD83+CCR7− DC, able to internalize live bacteria
[124].
PPs have a pivotal role in the interaction between
gut bacterial ﬂora and immune response/tolerance. Their
participation in digestive inﬂammatory disorders such as CD
and their interplay with the function and diversity of the gut
microbiota is becoming a productive ﬁeld of research.
4.2. Graft versus Host Disease. Like for CD, in acute GVHD,
the interplay between the bacterial ﬂora and the epithelial
immune response contributes to inﬂammatory signals that
enhance the donor-derived T cells stimulation by host
antigen-presenting cells. The ﬁrst evidence of the role of
GALT in GVHD was provided by Bekkum and coworkers in
1974 when they reported that germ-free mice were resistant
to enteric GVHD in a model of irradiation followed by
incompatible bone marrow transplantation. Using a model
of acute GVHD in PP-deﬁcient mice, Murai et al. demon-
strated that PPs are the anatomical site for the inﬁltration
of donor CD8+ T-cells and generation of antihost cytotoxic
T-cells [101]. However, other authors reported that PPs
are not required for the induction of acute GVHD when
myeloablative conditioning is applied before bone marrow
transplantation [125]. Thus, even if the implication of PP in
thepathogenesisofacuteGVHDisstillindebate,PPsthatare
at the interface between bacterial ﬂora and immune response
have a pivotal role in alloresponse and inﬂammation.
5. ConclusiveRemarks
PPs are key players of the mucosal immune host response
toward gut antigens and bacteria. Their function remains
to be clariﬁed in many aspects including the regulation of
T-cell diﬀerentiation after antigen exposure. Nod2 seems
to play a crucial role at the interface between innate and
adaptive immunity in PPs. It is involved in PP development
in response to the commensal ﬂora. It also plays a role
in PP permeability, translocation and response toward
pathogenic bacteria which exploit PP for their virulence.
These ﬁndings may be helpful to better understand the
mechanisms involved in NOD2 associated diseases like CD
and GVHD.8 International Journal of Inﬂammation
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